Treatments:Cancer - Revision history

Alexander Berchansky at 10:50, 5 February 2024

Alexander Berchansky — Mon, 05 Feb 2024 10:50:59 GMT

←Older revision		Revision as of 10:50, 5 February 2024
Line 39:		Line 39:
	=====[[Vascular Endothelial Growth Factor]] Inhibitor=====		=====[[Vascular Endothelial Growth Factor]] Inhibitor=====
	* [[Avastin]] - Generic: [[Bevacizumab]]		* [[Avastin]] - Generic: [[Bevacizumab]]
-	=====Poly ADP ribose polymerase (PARP) inhibitors======	+	=====Poly ADP ribose polymerase (PARP) inhibitors=====
	* [[Olaparib]] - brand name [[Lynparza]]		* [[Olaparib]] - brand name [[Lynparza]]
	=====[[Cyclin-dependent kinases]] inhibitors=====		=====[[Cyclin-dependent kinases]] inhibitors=====

Alexander Berchansky — Sun, 05 Nov 2023 10:47:00 GMT

←Older revision		Revision as of 10:47, 5 November 2023
Line 44:		Line 44:
	* [[Palbociclib]] - brand name [[Ibrance]]		* [[Palbociclib]] - brand name [[Ibrance]]
	* [[Abemaciclib]] - brand name [[Verzenio]]		* [[Abemaciclib]] - brand name [[Verzenio]]
		+	* [[Ribociclib]] - brand name [[Kisqali]]
	</td>		</td>
	</tr>		</tr>
	</table>		</table>
	__NOTOC__		__NOTOC__

Alexander Berchansky — Sun, 29 Oct 2023 10:54:56 GMT

←Older revision		Revision as of 10:54, 29 October 2023
Line 41:		Line 41:
	=====Poly ADP ribose polymerase (PARP) inhibitors======		=====Poly ADP ribose polymerase (PARP) inhibitors======
	* [[Olaparib]] - brand name [[Lynparza]]		* [[Olaparib]] - brand name [[Lynparza]]
		+	=====[[Cyclin-dependent kinases]] inhibitors=====
		+	* [[Palbociclib]] - brand name [[Ibrance]]
		+	* [[Abemaciclib]] - brand name [[Verzenio]]
	</td>		</td>
	</tr>		</tr>
	</table>		</table>
	__NOTOC__		__NOTOC__

Alexander Berchansky — Sun, 22 Oct 2023 07:00:11 GMT

←Older revision		Revision as of 07:00, 22 October 2023
Line 11:		Line 11:
	* Zelboraf - Generic: Vemurafenib (Formerly: PLX-4032)		* Zelboraf - Generic: Vemurafenib (Formerly: PLX-4032)
	=====Chemotherapy=====		=====Chemotherapy=====
-	* Platinol - Generic: [[Cisplatin]]	+	* [[Platinol]] - Generic: [[Cisplatin]]
	=====[[Dihydrofolate reductase\|Dihydrofolate Reductase]] Inhibitor=====		=====[[Dihydrofolate reductase\|Dihydrofolate Reductase]] Inhibitor=====
	* Alimta - Generic: Pemetrexed		* Alimta - Generic: Pemetrexed

Alexander Berchansky — Sun, 22 Oct 2023 06:59:32 GMT

←Older revision		Revision as of 06:59, 22 October 2023
Line 15:		Line 15:
	* Alimta - Generic: Pemetrexed		* Alimta - Generic: Pemetrexed
	* Folotyn - Generic: Pralatrexate		* Folotyn - Generic: Pralatrexate
-	* [[Methotrexate]]	+	* [[Methotrexate]] - Trade names: [[Trexall]], [[Rheumatrex]], [[Otrexup]]
	* Raltitrexed		* Raltitrexed
	=====[[Epidermal Growth Factor Receptor]] Inhibitors=====		=====[[Epidermal Growth Factor Receptor]] Inhibitors=====

Alexander Berchansky — Sun, 22 Oct 2023 06:51:02 GMT

←Older revision		Revision as of 06:51, 22 October 2023
Line 17:		Line 17:
	* [[Methotrexate]]		* [[Methotrexate]]
	* Raltitrexed		* Raltitrexed
-	=====[[Epidermal Growth Factor Receptor]] ~~Inhibitor~~=====	+	=====[[Epidermal Growth Factor Receptor]] Inhibitors=====
	* [[Herceptin]] - Generic: [[Trastuzumab]]		* [[Herceptin]] - Generic: [[Trastuzumab]]
	* [[Iressa]] - Generic: [[Gefitinib]]		* [[Iressa]] - Generic: [[Gefitinib]]
Line 30:		Line 30:
	* Afinitor - Generic: Everolimus		* Afinitor - Generic: Everolimus
	* Torisel - Generic: Temsirolimus		* Torisel - Generic: Temsirolimus
-	=====Multiple Receptor [[Tyrosine kinase]] ([[VEGFR]], PDGFR, [[EGFR]], KIT, Abl) ~~Inhibitor~~=====	+	=====Multiple Receptor [[Tyrosine kinase]] ([[VEGFR]], PDGFR, [[EGFR]], KIT, Abl) Inhibitors=====
	* [[Gleevec]] - Generic: [[Imatinib]]		* [[Gleevec]] - Generic: [[Imatinib]]
	* [[Nexavar]] - Generic: [[Sorafenib]]		* [[Nexavar]] - Generic: [[Sorafenib]]
Line 39:		Line 39:
	=====[[Vascular Endothelial Growth Factor]] Inhibitor=====		=====[[Vascular Endothelial Growth Factor]] Inhibitor=====
	* [[Avastin]] - Generic: [[Bevacizumab]]		* [[Avastin]] - Generic: [[Bevacizumab]]
		+	=====Poly ADP ribose polymerase (PARP) inhibitors======
		+	* [[Olaparib]] - brand name [[Lynparza]]
	</td>		</td>
	</tr>		</tr>
	</table>		</table>
	__NOTOC__		__NOTOC__

Alexander Berchansky — Sun, 08 Oct 2023 13:27:31 GMT

←Older revision		Revision as of 13:27, 8 October 2023
Line 36:		Line 36:
	* [[Sutent]] - Generic: [[Sunitinib]]		* [[Sutent]] - Generic: [[Sunitinib]]
	* [[Tasigna]] - Generic: [[Nilotinib]]		* [[Tasigna]] - Generic: [[Nilotinib]]
		+	* [[Ibrutinib]] - brand name: [[Imbruvica]]
	=====[[Vascular Endothelial Growth Factor]] Inhibitor=====		=====[[Vascular Endothelial Growth Factor]] Inhibitor=====
	* [[Avastin]] - Generic: [[Bevacizumab]]		* [[Avastin]] - Generic: [[Bevacizumab]]

Alexander Berchansky — Wed, 23 Aug 2023 11:19:54 GMT

←Older revision		Revision as of 11:19, 23 August 2023
Line 23:		Line 23:
	* [[Tykerb]] - Generic: [[Lapatinib]]		* [[Tykerb]] - Generic: [[Lapatinib]]
	=====Estrogen Receptor Modulator=====		=====Estrogen Receptor Modulator=====
-	* Evista - Generic: Raloxifene	+	* [[Evista]] - Generic: [[Raloxifene]]
	* Fareston - Generic: Toremifene		* Fareston - Generic: Toremifene
	* [[Nolvadex]] - Generic: [[Tamoxifen]]		* [[Nolvadex]] - Generic: [[Tamoxifen]]

Karsten Theis — Wed, 17 Jul 2019 15:33:07 GMT

←Older revision		Revision as of 15:33, 17 July 2019
Line 28:		Line 28:
	=====mTOR inhibitor=====		=====mTOR inhibitor=====
	* Rapamune - Generic: Sirolimus ([[Rapamycin]])		* Rapamune - Generic: Sirolimus ([[Rapamycin]])
-	* Everolimus	+	* Afinitor - Generic: Everolimus
-	* Temsirolimus	+	* Torisel - Generic: Temsirolimus
	=====Multiple Receptor [[Tyrosine kinase]] ([[VEGFR]], PDGFR, [[EGFR]], KIT, Abl) Inhibitor=====		=====Multiple Receptor [[Tyrosine kinase]] ([[VEGFR]], PDGFR, [[EGFR]], KIT, Abl) Inhibitor=====
	* [[Gleevec]] - Generic: [[Imatinib]]		* [[Gleevec]] - Generic: [[Imatinib]]

Karsten Theis — Wed, 17 Jul 2019 15:29:11 GMT

←Older revision		Revision as of 15:29, 17 July 2019
Line 28:		Line 28:
	=====mTOR inhibitor=====		=====mTOR inhibitor=====
	* Rapamune - Generic: Sirolimus ([[Rapamycin]])		* Rapamune - Generic: Sirolimus ([[Rapamycin]])
		+	* Everolimus
		+	* Temsirolimus
	=====Multiple Receptor [[Tyrosine kinase]] ([[VEGFR]], PDGFR, [[EGFR]], KIT, Abl) Inhibitor=====		=====Multiple Receptor [[Tyrosine kinase]] ([[VEGFR]], PDGFR, [[EGFR]], KIT, Abl) Inhibitor=====
	* [[Gleevec]] - Generic: [[Imatinib]]		* [[Gleevec]] - Generic: [[Imatinib]]